Psychiatric Research

9/14/17
Desvenlafaxine Appears to Improve Low Energy in Major Depression
Desvenlafaxine appears to improve energy and diminish lassitude in patients with major depressive disorder (MDD), with a significant association between improvements in energy/fatigue and overall functional outcomes, according to a report in the Journal of Psychopharmacology.